Loading…

Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies

Aims/hypothesis Increased oxidative-nitrosative stress, poly(ADP-ribose) polymerase (PARP) activation and subsequent cellular damage play important roles in the complications of both diabetes mellitus and pregnancy. Our aim was to investigate nitrative stress and PARP activity levels during normal a...

Full description

Saved in:
Bibliographic Details
Published in:Diabetologia 2009-09, Vol.52 (9), p.1935-1943
Main Authors: Horváth, E. M, Magenheim, R, Kugler, E, Vácz, G, Szigethy, A, Lévárdi, F, Kollai, M, Szabo, C, Lacza, Z
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c467t-936d391a8bcb0de2acf4ca6fa55294a3206daad95d121e2113d98f782c286d753
cites cdi_FETCH-LOGICAL-c467t-936d391a8bcb0de2acf4ca6fa55294a3206daad95d121e2113d98f782c286d753
container_end_page 1943
container_issue 9
container_start_page 1935
container_title Diabetologia
container_volume 52
creator Horváth, E. M
Magenheim, R
Kugler, E
Vácz, G
Szigethy, A
Lévárdi, F
Kollai, M
Szabo, C
Lacza, Z
description Aims/hypothesis Increased oxidative-nitrosative stress, poly(ADP-ribose) polymerase (PARP) activation and subsequent cellular damage play important roles in the complications of both diabetes mellitus and pregnancy. Our aim was to investigate nitrative stress and PARP activity levels during normal and gestational diabetic (GDM) pregnancy in both maternal and fetal tissues. Methods Blood samples were collected during pregnancy (weeks 16-29 and 36-40), and placental and umbilical cord tissues were harvested after delivery from healthy volunteers and GDM patients subjected to a carbohydrate-restricted diet or insulin treatment. Immunohistochemical staining was performed on leucocytes and tissue sections using anti-nitrotyrosine (NT), anti-poly(ADP-ribose) (PAR) and anti-apoptosis inducing factor antibodies. Results In healthy pregnancies the intensity of NT and PAR staining of leucocytes correlated positively with gestational week (R ² = 0.43, p < 0.01 and R ² = 0.49, p < 0.001, respectively). In patients on a carbohydrate-restricted diet PAR staining was already strong in weeks 16-29 (p < 0.001 vs control) and did not increase further. In weeks 16-29 there was a correlation between PAR staining and the 2 h value of the oral glucose tolerance test (R ² = 0.49, p < 0.001). Patients with the highest level of leucocyte PARP activity later required insulin therapy, which decreased the intensity of NT and PAR staining. Placental and umbilical cord tissues also had a higher level of nitrative stress markers in GDM pregnancies, but the highest level of PARP activity was observed after insulin therapy. Conclusions/interpretation Continuous elevation of tyrosine nitration and PARP activation may be considered physiological during pregnancy. However, the high level of PARP activity in early pregnancy may signal the subsequent development of severe GDM.
doi_str_mv 10.1007/s00125-009-1435-3
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_213845718</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1823803541</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-936d391a8bcb0de2acf4ca6fa55294a3206daad95d121e2113d98f782c286d753</originalsourceid><addsrcrecordid>eNp9kE-LFDEQxYMo7rj6AbxoIwh6iFYlnXRyXNa_sKigC95CdZKe7bWne0x6hPn2ZqYH9-YpIe_3ql4eY08R3iBA8zYDoFAcwHKspeLyHluVi-BQC3OfrQ4yR6N_nrFHOd8CgFS1fsjO0CrbGIAV-_WlnxPN_Z9Y5TnFnCsaQ7Wdhv2ri3ffeOrbKcfXx4dNTJRjRb7QxTGNVT9WN5GG-WZ_dK1jno8CDVXoqY1z76ttiuuRRt_H_Jg96GjI8cnpPGfXH97_uPzEr75-_Hx5ccV9rZuZW6mDtEim9S2EKMh3tSfdkVLC1iQF6EAUrAooMApEGazpGiO8MDo0Sp6zF8vcbZp-70oodzvtUkmVnUBpatWgKRAukE9Tzil2bpv6DaW9Q3CHdt3SrivtukO7ThbPs9PgXbuJ4c5xqrMAL08AZU9Dlw4fz_84gUZZqOvCiYXLRRrXMd0l_N_254upo8nROpXB198FoATUWhsj5F-xtpwH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>213845718</pqid></control><display><type>article</type><title>Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies</title><source>Springer Link</source><creator>Horváth, E. M ; Magenheim, R ; Kugler, E ; Vácz, G ; Szigethy, A ; Lévárdi, F ; Kollai, M ; Szabo, C ; Lacza, Z</creator><creatorcontrib>Horváth, E. M ; Magenheim, R ; Kugler, E ; Vácz, G ; Szigethy, A ; Lévárdi, F ; Kollai, M ; Szabo, C ; Lacza, Z</creatorcontrib><description>Aims/hypothesis Increased oxidative-nitrosative stress, poly(ADP-ribose) polymerase (PARP) activation and subsequent cellular damage play important roles in the complications of both diabetes mellitus and pregnancy. Our aim was to investigate nitrative stress and PARP activity levels during normal and gestational diabetic (GDM) pregnancy in both maternal and fetal tissues. Methods Blood samples were collected during pregnancy (weeks 16-29 and 36-40), and placental and umbilical cord tissues were harvested after delivery from healthy volunteers and GDM patients subjected to a carbohydrate-restricted diet or insulin treatment. Immunohistochemical staining was performed on leucocytes and tissue sections using anti-nitrotyrosine (NT), anti-poly(ADP-ribose) (PAR) and anti-apoptosis inducing factor antibodies. Results In healthy pregnancies the intensity of NT and PAR staining of leucocytes correlated positively with gestational week (R ² = 0.43, p &lt; 0.01 and R ² = 0.49, p &lt; 0.001, respectively). In patients on a carbohydrate-restricted diet PAR staining was already strong in weeks 16-29 (p &lt; 0.001 vs control) and did not increase further. In weeks 16-29 there was a correlation between PAR staining and the 2 h value of the oral glucose tolerance test (R ² = 0.49, p &lt; 0.001). Patients with the highest level of leucocyte PARP activity later required insulin therapy, which decreased the intensity of NT and PAR staining. Placental and umbilical cord tissues also had a higher level of nitrative stress markers in GDM pregnancies, but the highest level of PARP activity was observed after insulin therapy. Conclusions/interpretation Continuous elevation of tyrosine nitration and PARP activation may be considered physiological during pregnancy. However, the high level of PARP activity in early pregnancy may signal the subsequent development of severe GDM.</description><identifier>ISSN: 0012-186X</identifier><identifier>EISSN: 1432-0428</identifier><identifier>DOI: 10.1007/s00125-009-1435-3</identifier><identifier>PMID: 19597800</identifier><language>eng</language><publisher>Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag</publisher><subject>Adult ; Apoptosis ; Biological and medical sciences ; Birth Weight ; Blood Glucose - analysis ; Body Mass Index ; Carbohydrates ; Diabetes, Gestational - blood ; Diabetes, Gestational - drug therapy ; Diabetes, Gestational - enzymology ; Diabetes. Impaired glucose tolerance ; Diet, Diabetic ; Dietary restrictions ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Enzyme Activation ; Female ; Gestational diabetes ; Glucose ; Glucose Tolerance Test ; Human Physiology ; Humans ; Hypoglycemic Agents - therapeutic use ; Infant, Newborn ; Infant, Small for Gestational Age ; Insulin ; Insulin - therapeutic use ; Internal Medicine ; Leukocytes ; Leukocytes - cytology ; Medical sciences ; Medicine ; Medicine &amp; Public Health ; Metabolic Diseases ; Obstetric Labor, Premature ; Oxidative stress ; Parity ; Physiology ; Poly(ADP-ribose) Polymerases - metabolism ; Pregnancy ; Pregnancy - blood ; Pregnancy - physiology ; Reference Values ; Umbilical cord ; Weight Gain</subject><ispartof>Diabetologia, 2009-09, Vol.52 (9), p.1935-1943</ispartof><rights>Springer-Verlag 2009</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-936d391a8bcb0de2acf4ca6fa55294a3206daad95d121e2113d98f782c286d753</citedby><cites>FETCH-LOGICAL-c467t-936d391a8bcb0de2acf4ca6fa55294a3206daad95d121e2113d98f782c286d753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21859044$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19597800$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Horváth, E. M</creatorcontrib><creatorcontrib>Magenheim, R</creatorcontrib><creatorcontrib>Kugler, E</creatorcontrib><creatorcontrib>Vácz, G</creatorcontrib><creatorcontrib>Szigethy, A</creatorcontrib><creatorcontrib>Lévárdi, F</creatorcontrib><creatorcontrib>Kollai, M</creatorcontrib><creatorcontrib>Szabo, C</creatorcontrib><creatorcontrib>Lacza, Z</creatorcontrib><title>Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies</title><title>Diabetologia</title><addtitle>Diabetologia</addtitle><addtitle>Diabetologia</addtitle><description>Aims/hypothesis Increased oxidative-nitrosative stress, poly(ADP-ribose) polymerase (PARP) activation and subsequent cellular damage play important roles in the complications of both diabetes mellitus and pregnancy. Our aim was to investigate nitrative stress and PARP activity levels during normal and gestational diabetic (GDM) pregnancy in both maternal and fetal tissues. Methods Blood samples were collected during pregnancy (weeks 16-29 and 36-40), and placental and umbilical cord tissues were harvested after delivery from healthy volunteers and GDM patients subjected to a carbohydrate-restricted diet or insulin treatment. Immunohistochemical staining was performed on leucocytes and tissue sections using anti-nitrotyrosine (NT), anti-poly(ADP-ribose) (PAR) and anti-apoptosis inducing factor antibodies. Results In healthy pregnancies the intensity of NT and PAR staining of leucocytes correlated positively with gestational week (R ² = 0.43, p &lt; 0.01 and R ² = 0.49, p &lt; 0.001, respectively). In patients on a carbohydrate-restricted diet PAR staining was already strong in weeks 16-29 (p &lt; 0.001 vs control) and did not increase further. In weeks 16-29 there was a correlation between PAR staining and the 2 h value of the oral glucose tolerance test (R ² = 0.49, p &lt; 0.001). Patients with the highest level of leucocyte PARP activity later required insulin therapy, which decreased the intensity of NT and PAR staining. Placental and umbilical cord tissues also had a higher level of nitrative stress markers in GDM pregnancies, but the highest level of PARP activity was observed after insulin therapy. Conclusions/interpretation Continuous elevation of tyrosine nitration and PARP activation may be considered physiological during pregnancy. However, the high level of PARP activity in early pregnancy may signal the subsequent development of severe GDM.</description><subject>Adult</subject><subject>Apoptosis</subject><subject>Biological and medical sciences</subject><subject>Birth Weight</subject><subject>Blood Glucose - analysis</subject><subject>Body Mass Index</subject><subject>Carbohydrates</subject><subject>Diabetes, Gestational - blood</subject><subject>Diabetes, Gestational - drug therapy</subject><subject>Diabetes, Gestational - enzymology</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Diet, Diabetic</subject><subject>Dietary restrictions</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Enzyme Activation</subject><subject>Female</subject><subject>Gestational diabetes</subject><subject>Glucose</subject><subject>Glucose Tolerance Test</subject><subject>Human Physiology</subject><subject>Humans</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Infant, Newborn</subject><subject>Infant, Small for Gestational Age</subject><subject>Insulin</subject><subject>Insulin - therapeutic use</subject><subject>Internal Medicine</subject><subject>Leukocytes</subject><subject>Leukocytes - cytology</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metabolic Diseases</subject><subject>Obstetric Labor, Premature</subject><subject>Oxidative stress</subject><subject>Parity</subject><subject>Physiology</subject><subject>Poly(ADP-ribose) Polymerases - metabolism</subject><subject>Pregnancy</subject><subject>Pregnancy - blood</subject><subject>Pregnancy - physiology</subject><subject>Reference Values</subject><subject>Umbilical cord</subject><subject>Weight Gain</subject><issn>0012-186X</issn><issn>1432-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9kE-LFDEQxYMo7rj6AbxoIwh6iFYlnXRyXNa_sKigC95CdZKe7bWne0x6hPn2ZqYH9-YpIe_3ql4eY08R3iBA8zYDoFAcwHKspeLyHluVi-BQC3OfrQ4yR6N_nrFHOd8CgFS1fsjO0CrbGIAV-_WlnxPN_Z9Y5TnFnCsaQ7Wdhv2ri3ffeOrbKcfXx4dNTJRjRb7QxTGNVT9WN5GG-WZ_dK1jno8CDVXoqY1z76ttiuuRRt_H_Jg96GjI8cnpPGfXH97_uPzEr75-_Hx5ccV9rZuZW6mDtEim9S2EKMh3tSfdkVLC1iQF6EAUrAooMApEGazpGiO8MDo0Sp6zF8vcbZp-70oodzvtUkmVnUBpatWgKRAukE9Tzil2bpv6DaW9Q3CHdt3SrivtukO7ThbPs9PgXbuJ4c5xqrMAL08AZU9Dlw4fz_84gUZZqOvCiYXLRRrXMd0l_N_254upo8nROpXB198FoATUWhsj5F-xtpwH</recordid><startdate>20090901</startdate><enddate>20090901</enddate><creator>Horváth, E. M</creator><creator>Magenheim, R</creator><creator>Kugler, E</creator><creator>Vácz, G</creator><creator>Szigethy, A</creator><creator>Lévárdi, F</creator><creator>Kollai, M</creator><creator>Szabo, C</creator><creator>Lacza, Z</creator><general>Berlin/Heidelberg : Springer-Verlag</general><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20090901</creationdate><title>Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies</title><author>Horváth, E. M ; Magenheim, R ; Kugler, E ; Vácz, G ; Szigethy, A ; Lévárdi, F ; Kollai, M ; Szabo, C ; Lacza, Z</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-936d391a8bcb0de2acf4ca6fa55294a3206daad95d121e2113d98f782c286d753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Apoptosis</topic><topic>Biological and medical sciences</topic><topic>Birth Weight</topic><topic>Blood Glucose - analysis</topic><topic>Body Mass Index</topic><topic>Carbohydrates</topic><topic>Diabetes, Gestational - blood</topic><topic>Diabetes, Gestational - drug therapy</topic><topic>Diabetes, Gestational - enzymology</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Diet, Diabetic</topic><topic>Dietary restrictions</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Enzyme Activation</topic><topic>Female</topic><topic>Gestational diabetes</topic><topic>Glucose</topic><topic>Glucose Tolerance Test</topic><topic>Human Physiology</topic><topic>Humans</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Infant, Newborn</topic><topic>Infant, Small for Gestational Age</topic><topic>Insulin</topic><topic>Insulin - therapeutic use</topic><topic>Internal Medicine</topic><topic>Leukocytes</topic><topic>Leukocytes - cytology</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metabolic Diseases</topic><topic>Obstetric Labor, Premature</topic><topic>Oxidative stress</topic><topic>Parity</topic><topic>Physiology</topic><topic>Poly(ADP-ribose) Polymerases - metabolism</topic><topic>Pregnancy</topic><topic>Pregnancy - blood</topic><topic>Pregnancy - physiology</topic><topic>Reference Values</topic><topic>Umbilical cord</topic><topic>Weight Gain</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Horváth, E. M</creatorcontrib><creatorcontrib>Magenheim, R</creatorcontrib><creatorcontrib>Kugler, E</creatorcontrib><creatorcontrib>Vácz, G</creatorcontrib><creatorcontrib>Szigethy, A</creatorcontrib><creatorcontrib>Lévárdi, F</creatorcontrib><creatorcontrib>Kollai, M</creatorcontrib><creatorcontrib>Szabo, C</creatorcontrib><creatorcontrib>Lacza, Z</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Diabetologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Horváth, E. M</au><au>Magenheim, R</au><au>Kugler, E</au><au>Vácz, G</au><au>Szigethy, A</au><au>Lévárdi, F</au><au>Kollai, M</au><au>Szabo, C</au><au>Lacza, Z</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies</atitle><jtitle>Diabetologia</jtitle><stitle>Diabetologia</stitle><addtitle>Diabetologia</addtitle><date>2009-09-01</date><risdate>2009</risdate><volume>52</volume><issue>9</issue><spage>1935</spage><epage>1943</epage><pages>1935-1943</pages><issn>0012-186X</issn><eissn>1432-0428</eissn><abstract>Aims/hypothesis Increased oxidative-nitrosative stress, poly(ADP-ribose) polymerase (PARP) activation and subsequent cellular damage play important roles in the complications of both diabetes mellitus and pregnancy. Our aim was to investigate nitrative stress and PARP activity levels during normal and gestational diabetic (GDM) pregnancy in both maternal and fetal tissues. Methods Blood samples were collected during pregnancy (weeks 16-29 and 36-40), and placental and umbilical cord tissues were harvested after delivery from healthy volunteers and GDM patients subjected to a carbohydrate-restricted diet or insulin treatment. Immunohistochemical staining was performed on leucocytes and tissue sections using anti-nitrotyrosine (NT), anti-poly(ADP-ribose) (PAR) and anti-apoptosis inducing factor antibodies. Results In healthy pregnancies the intensity of NT and PAR staining of leucocytes correlated positively with gestational week (R ² = 0.43, p &lt; 0.01 and R ² = 0.49, p &lt; 0.001, respectively). In patients on a carbohydrate-restricted diet PAR staining was already strong in weeks 16-29 (p &lt; 0.001 vs control) and did not increase further. In weeks 16-29 there was a correlation between PAR staining and the 2 h value of the oral glucose tolerance test (R ² = 0.49, p &lt; 0.001). Patients with the highest level of leucocyte PARP activity later required insulin therapy, which decreased the intensity of NT and PAR staining. Placental and umbilical cord tissues also had a higher level of nitrative stress markers in GDM pregnancies, but the highest level of PARP activity was observed after insulin therapy. Conclusions/interpretation Continuous elevation of tyrosine nitration and PARP activation may be considered physiological during pregnancy. However, the high level of PARP activity in early pregnancy may signal the subsequent development of severe GDM.</abstract><cop>Berlin/Heidelberg</cop><pub>Berlin/Heidelberg : Springer-Verlag</pub><pmid>19597800</pmid><doi>10.1007/s00125-009-1435-3</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-186X
ispartof Diabetologia, 2009-09, Vol.52 (9), p.1935-1943
issn 0012-186X
1432-0428
language eng
recordid cdi_proquest_journals_213845718
source Springer Link
subjects Adult
Apoptosis
Biological and medical sciences
Birth Weight
Blood Glucose - analysis
Body Mass Index
Carbohydrates
Diabetes, Gestational - blood
Diabetes, Gestational - drug therapy
Diabetes, Gestational - enzymology
Diabetes. Impaired glucose tolerance
Diet, Diabetic
Dietary restrictions
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Enzyme Activation
Female
Gestational diabetes
Glucose
Glucose Tolerance Test
Human Physiology
Humans
Hypoglycemic Agents - therapeutic use
Infant, Newborn
Infant, Small for Gestational Age
Insulin
Insulin - therapeutic use
Internal Medicine
Leukocytes
Leukocytes - cytology
Medical sciences
Medicine
Medicine & Public Health
Metabolic Diseases
Obstetric Labor, Premature
Oxidative stress
Parity
Physiology
Poly(ADP-ribose) Polymerases - metabolism
Pregnancy
Pregnancy - blood
Pregnancy - physiology
Reference Values
Umbilical cord
Weight Gain
title Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T13%3A17%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nitrative%20stress%20and%20poly(ADP-ribose)%20polymerase%20activation%20in%20healthy%20and%20gestational%20diabetic%20pregnancies&rft.jtitle=Diabetologia&rft.au=Horv%C3%A1th,%20E.%20M&rft.date=2009-09-01&rft.volume=52&rft.issue=9&rft.spage=1935&rft.epage=1943&rft.pages=1935-1943&rft.issn=0012-186X&rft.eissn=1432-0428&rft_id=info:doi/10.1007/s00125-009-1435-3&rft_dat=%3Cproquest_cross%3E1823803541%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c467t-936d391a8bcb0de2acf4ca6fa55294a3206daad95d121e2113d98f782c286d753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=213845718&rft_id=info:pmid/19597800&rfr_iscdi=true